Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
* Rituxan - Generic: Rituximab | * Rituxan - Generic: Rituximab | ||
* Zevalin - Generic: Ibritumomab | * Zevalin - Generic: Ibritumomab | ||
| - | =====BCR-Abl Tyrosine Kinase Inhibitor===== | ||
| - | * [[Gleevec]] - Generic: Imatinib | ||
| - | * Tasigna - Generic: Nilotinib | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
* [[Herceptin]] - Generic: Trastuzumab | * [[Herceptin]] - Generic: Trastuzumab | ||
| Line 19: | Line 16: | ||
* Fareston - Generic: Toremifene | * Fareston - Generic: Toremifene | ||
* Nolvadex - Generic: Tamoxifen | * Nolvadex - Generic: Tamoxifen | ||
| - | ===== | + | =====Multiple Receptor Tyrosine Kinase ([[VEGFR]], PDGFR, KIT, Abl) Inhibitor===== |
* [[Gleevec]] - Generic: Imatinib | * [[Gleevec]] - Generic: Imatinib | ||
| + | * [[Nexavar]] - Generic: Sorafenib | ||
| + | * [[Sutent]] - Generic: Sunitinib | ||
| + | * Tasigna - Generic: Nilotinib | ||
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
* [[Avastin]] - Generic: Bevacizumab | * [[Avastin]] - Generic: Bevacizumab | ||
| - | =====[[Vascular Endothelial Growth Factor Receptor]] & KIT Inhibitor===== | ||
| - | * [[Sutent]] - Generic: Sunitinib | ||
| - | * [[Nexavar]] - Generic: Sorafenib | ||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 15:40, 10 December 2010
Anti-CD20 Monoclonal Antibody
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Antagonist
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
